Junming Xu

543 total citations
27 papers, 402 citations indexed

About

Junming Xu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Junming Xu has authored 27 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Junming Xu's work include Epigenetics and DNA Methylation (4 papers), Cancer-related molecular mechanisms research (3 papers) and Tryptophan and brain disorders (3 papers). Junming Xu is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Cancer-related molecular mechanisms research (3 papers) and Tryptophan and brain disorders (3 papers). Junming Xu collaborates with scholars based in China, United States and Hong Kong. Junming Xu's co-authors include Tao Jin, Junyi Wu, Jun Qin, Fangbin Song, Shanbao Li, Yang Li, Ye Wang, Lei Li, Tao Wang and Chao Xiao and has published in prestigious journals such as Oncogene, European Journal of Pharmacology and World Journal of Gastroenterology.

In The Last Decade

Junming Xu

26 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junming Xu China 12 239 140 97 74 39 27 402
Xiaojun Zheng China 10 231 1.0× 141 1.0× 92 0.9× 81 1.1× 139 3.6× 19 534
Gillian Moore Ireland 9 178 0.7× 90 0.6× 130 1.3× 45 0.6× 68 1.7× 16 414
Silin Lv China 11 209 0.9× 54 0.4× 69 0.7× 76 1.0× 105 2.7× 20 404
Christine Mall United States 5 211 0.9× 144 1.0× 95 1.0× 49 0.7× 90 2.3× 7 403
Siyuan He China 8 205 0.9× 123 0.9× 51 0.5× 40 0.5× 84 2.2× 18 401
Qiuju Fan China 11 279 1.2× 104 0.7× 67 0.7× 40 0.5× 64 1.6× 17 387
Agnieszka Bielska Poland 10 223 0.9× 187 1.3× 36 0.4× 92 1.2× 43 1.1× 14 389
Ezra Ella Israel 9 195 0.8× 75 0.5× 62 0.6× 33 0.4× 44 1.1× 9 319
Seongki Min South Korea 10 216 0.9× 112 0.8× 36 0.4× 40 0.5× 38 1.0× 13 325

Countries citing papers authored by Junming Xu

Since Specialization
Citations

This map shows the geographic impact of Junming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junming Xu more than expected).

Fields of papers citing papers by Junming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junming Xu. The network helps show where Junming Xu may publish in the future.

Co-authorship network of co-authors of Junming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Junming Xu. A scholar is included among the top collaborators of Junming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junming Xu. Junming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Haijiao, et al.. (2024). FEN1 Promotes Hepatocellular Carcinoma Progression by Activating Cell Cycle Transition from G2 To M Phase. Journal of Cancer. 15(4). 981–989. 5 indexed citations
3.
Li, Huang, et al.. (2023). A comprehensive analysis of the expression and the prognosis for LOX-1 in multiple cancer types. Biotechnology and Genetic Engineering Reviews. 40(3). 2346–2368. 1 indexed citations
4.
Wang, Tao, et al.. (2022). TOP2A promotes proliferation and metastasis of hepatocellular carcinoma regulated by miR-144-3p. Journal of Cancer. 13(2). 589–601. 41 indexed citations
5.
Li, Shanbao, Lei Li, Fangbin Song, et al.. (2020). <p>TDO Promotes Hepatocellular Carcinoma Progression</p>. OncoTargets and Therapy. Volume 13. 5845–5855. 24 indexed citations
6.
Li, Yang, et al.. (2020). High expression of OSR1 as a predictive biomarker for poor prognosis and lymph node metastasis in breast cancer. Breast Cancer Research and Treatment. 182(1). 35–46. 14 indexed citations
7.
Li, Shanbao, Junyong Weng, Fangbin Song, et al.. (2020). Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression. Cell Death and Disease. 11(6). 452–452. 37 indexed citations
8.
Xu, Junming, et al.. (2020). SOX12 expression is associated with progression and poor prognosis in human breast cancer.. PubMed. 12(12). 8162–8174. 11 indexed citations
9.
Wu, Junyi, Lei Li, Jiayi Chen, et al.. (2020). Clinical value of CTLA4 combined with clinicopathological factors in evaluating the prognosis of breast cancer. Gland Surgery. 9(5). 1328–1337. 7 indexed citations
11.
Chao, Jiashuo, Senlin Zhao, Yongbing Qian, et al.. (2019). Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation. World Journal of Gastroenterology. 25(37). 5630–5640. 4 indexed citations
12.
Li, Yang, et al.. (2018). Meta-analysis of diffusion-weighted imaging in the differential diagnosis of renal lesions. Clinical Imaging. 52. 264–272. 6 indexed citations
13.
Wang, Min, et al.. (2016). Could Tumor Size Be A Predictor for Papillary Thyroid Microcarcinoma: a Retrospective Cohort Study. Asian Pacific Journal of Cancer Prevention. 16(18). 8625–8628. 16 indexed citations
14.
Xu, Junming, Fangbin Song, Tao Jin, et al.. (2015). Prognostic values of Notch receptors in breast cancer. Tumor Biology. 37(2). 1871–1877. 21 indexed citations
15.
Zhang, Jinyan, Tao Huang, Fan Zhang, et al.. (2015). Prognostic role of serum carbohydrate antigen 19-9 levels in patients with resectable hepatocellular carcinoma. Tumor Biology. 36(4). 2257–2261. 9 indexed citations
16.
Xu, Junming, et al.. (2015). The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review. Drug Design Development and Therapy. 9. 5439–5439. 11 indexed citations
18.
Weng, Mingzhe, Fangbin Song, Jinyu Chen, et al.. (2014). The high-mobility group nucleosome-binding domain 5 is highly expressed in breast cancer and promotes the proliferation and invasion of breast cancer cells. Tumor Biology. 36(2). 959–966. 20 indexed citations
19.
Sun, Xing, et al.. (2014). Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population. Tumor Biology. 35(3). 1757–1762. 15 indexed citations
20.
Yu, Ying, Junming Xu, Yibin Fang, et al.. (2013). Analysis of Morphologic and Hemodynamic Parameters for Unruptured Posterior Communicating Artery Aneurysms with Oculomotor Nerve Palsy. American Journal of Neuroradiology. 34(11). 2187–2191. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026